HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charles E Geyer Selected Research

desintegron B

5/2011Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.
4/2010Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charles E Geyer Research Topics

Disease

83Breast Neoplasms (Breast Cancer)
06/2022 - 01/2004
35Neoplasms (Cancer)
06/2022 - 07/2003
6Triple Negative Breast Neoplasms
11/2021 - 07/2014
6Pathologic Complete Response
11/2021 - 06/2008
6Neutropenia
09/2015 - 07/2003
4Amenorrhea
02/2022 - 06/2010
3Fatigue
01/2020 - 08/2011
3Cardiotoxicity
12/2017 - 01/2004
3Hypertension (High Blood Pressure)
12/2017 - 01/2012
3Hand-Foot Syndrome
09/2015 - 08/2011
3Heart Failure
11/2013 - 01/2004
2Adenocarcinoma
01/2021 - 09/2005
2Left Ventricular Dysfunction
01/2019 - 01/2012
2Mucositis
01/2012 - 08/2011
2Febrile Neutropenia
02/2010 - 06/2008
2Colorectal Neoplasms (Colorectal Cancer)
10/2008 - 09/2005
1Genomic Instability
11/2021
1COVID-19
12/2020
1Cognitive Dysfunction
10/2020
1Vomiting
01/2020
1Breast Diseases (Breast Disease)
01/2020
1Constipation
01/2020
1Nausea
01/2020
1Arthralgia (Joint Pain)
01/2019
1Residual Neoplasm
01/2019
1Urinary Tract Infections (Urinary Tract Infection)
01/2019
1Back Pain (Backache)
01/2019
1Second Primary Neoplasms (Neoplasms, Second)
07/2018
1Heart Diseases (Heart Disease)
12/2017
1Hyperlipidemias (Hyperlipidemia)
12/2017
1Sudden Death
09/2015
1Endocarditis
09/2015
1Margins of Excision
02/2014
1Unilateral Breast Neoplasms
02/2014
1Cardiovascular Diseases (Cardiovascular Disease)
11/2012

Drug/Important Bio-Agent (IBA)

31Trastuzumab (Herceptin)FDA Link
05/2021 - 10/2005
20Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2022 - 10/2005
19Doxorubicin (Adriamycin)FDA LinkGeneric
02/2022 - 01/2004
15AnthracyclinesIBA
06/2022 - 11/2005
14Hormones (Hormone)IBA
06/2022 - 04/2008
13Paclitaxel (Taxol)FDA LinkGeneric
01/2018 - 01/2004
12B 31IBA
10/2020 - 10/2005
12ErbB Receptors (EGF Receptor)IBA
01/2020 - 11/2005
12TamoxifenFDA LinkGeneric
01/2019 - 08/2006
11Docetaxel (Taxotere)FDA Link
08/2017 - 05/2006
10Estrogen ReceptorsIBA
10/2020 - 05/2006
10Lapatinib (GW572016)FDA Link
01/2020 - 12/2006
10Capecitabine (Xeloda)FDA Link
09/2015 - 12/2006
9human ERBB2 proteinIBA
01/2021 - 11/2005
8taxaneIBA
01/2020 - 12/2006
6Pharmaceutical PreparationsIBA
12/2020 - 07/2003
5Biomarkers (Surrogate Marker)IBA
01/2020 - 12/2008
5Bevacizumab (Avastin)FDA Link
07/2017 - 08/2011
5GemcitabineFDA Link
09/2015 - 01/2004
4Epirubicin (Ellence)FDA LinkGeneric
02/2022 - 06/2008
4exemestane (Aromasin)FDA Link
07/2018 - 04/2008
3RNA (Ribonucleic Acid)IBA
11/2021 - 06/2008
3Carboplatin (JM8)FDA LinkGeneric
11/2021 - 01/2018
3Aromatase InhibitorsIBA
01/2019 - 07/2014
2Fluorouracil (Carac)FDA LinkGeneric
02/2022 - 02/2010
2Poly(ADP-ribose) Polymerase InhibitorsIBA
11/2021 - 01/2018
2veliparibIBA
11/2021 - 01/2018
2olaparibIBA
10/2021 - 01/2021
2Progesterone Receptors (Progesterone Receptor)IBA
10/2020 - 04/2012
2Biological ProductsIBA
01/2020 - 04/2010
2Ado-Trastuzumab EmtansineIBA
01/2020 - 01/2019
2Pemetrexed (MTA)FDA Link
01/2016 - 09/2005
2ParaffinIBA
11/2015 - 11/2011
2Estrogens (Estrogen)FDA Link
01/2015 - 04/2012
2Dihydrotachysterol (AT 10)IBA
04/2012 - 08/2006
2Taxoids (Taxanes)IBA
01/2012 - 06/2010
2Proteins (Proteins, Gene)FDA Link
11/2011 - 12/2008
2Messenger RNA (mRNA)IBA
11/2011 - 12/2008
2desintegron BIBA
05/2011 - 04/2010
2Monoclonal AntibodiesIBA
03/2009 - 10/2008
1PlatinumIBA
11/2021
1Poly Adenosine Diphosphate RiboseIBA
01/2021
1Cytotoxins (Cytolysins)IBA
01/2019
1Maytansine (Maitansine)IBA
01/2019
1130-nm albumin-bound paclitaxelIBA
01/2019
1Letrozole (Femara)FDA LinkGeneric
01/2019
1Immunoconjugates (Immunoconjugate)IBA
01/2019
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2018
1Sorafenib (BAY 43-9006)FDA Link
01/2016
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2015
1Epidermal Growth Factor (EGF)IBA
12/2013
1neratinibIBA
12/2013
1OF 743IBA
11/2012
1Clodronic Acid (Clodronate)IBA
07/2012

Therapy/Procedure

45Therapeutics
02/2022 - 01/2004
27Drug Therapy (Chemotherapy)
06/2022 - 01/2004
19Neoadjuvant Therapy
11/2021 - 06/2008
19Adjuvant Chemotherapy
01/2021 - 01/2004
8Segmental Mastectomy (Lumpectomy)
06/2022 - 06/2008
3Mastectomy (Mammectomy)
02/2014 - 06/2008
2Simple Mastectomy
06/2022 - 10/2008
2Radiotherapy
01/2021 - 02/2014
2Combination Drug Therapy (Combination Chemotherapy)
11/2014 - 09/2013
2Aftercare (After-Treatment)
12/2008 - 12/2006
1Adjuvant Radiotherapy
11/2012